Point72 Asset Management L.P. Invests $850,000 in Fresenius Medical Care AG (NYSE:FMS)

Point72 Asset Management L.P. purchased a new position in shares of Fresenius Medical Care AG (NYSE:FMS - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 37,539 shares of the company's stock, valued at approximately $850,000.

A number of other institutional investors and hedge funds have also made changes to their positions in FMS. Smartleaf Asset Management LLC increased its stake in shares of Fresenius Medical Care by 192.8% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock worth $28,000 after acquiring an additional 806 shares during the period. Russell Investments Group Ltd. grew its position in Fresenius Medical Care by 234.1% during the fourth quarter. Russell Investments Group Ltd. now owns 3,151 shares of the company's stock worth $71,000 after buying an additional 2,208 shares during the period. Jones Financial Companies Lllp grew its position in Fresenius Medical Care by 80.5% during the fourth quarter. Jones Financial Companies Lllp now owns 4,510 shares of the company's stock worth $102,000 after buying an additional 2,012 shares during the period. Venturi Wealth Management LLC grew its position in Fresenius Medical Care by 8.4% during the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company's stock worth $129,000 after buying an additional 441 shares during the period. Finally, Assetmark Inc. grew its position in Fresenius Medical Care by 196.3% during the fourth quarter. Assetmark Inc. now owns 7,210 shares of the company's stock worth $163,000 after buying an additional 4,777 shares during the period. 8.37% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have weighed in on FMS shares. Truist Financial upped their target price on shares of Fresenius Medical Care from $25.00 to $30.00 and gave the stock a "hold" rating in a research report on Monday, May 12th. Wall Street Zen started coverage on shares of Fresenius Medical Care in a research report on Tuesday. They set a "strong-buy" rating on the stock. Finally, Morgan Stanley restated an "underweight" rating on shares of Fresenius Medical Care in a research report on Thursday, May 15th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, one has given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $27.80.

Fresenius Medical Care Stock Down 1.7%

Shares of NYSE FMS opened at $29.30 on Friday. Fresenius Medical Care AG has a 12-month low of $17.93 and a 12-month high of $30.46. The company has a market capitalization of $17.20 billion, a PE ratio of 24.22, a price-to-earnings-growth ratio of 0.76 and a beta of 0.85. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02. The firm's 50-day moving average is $25.44 and its two-hundred day moving average is $23.94.

Fresenius Medical Care (NYSE:FMS - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.01. Fresenius Medical Care had a net margin of 3.43% and a return on equity of 6.04%. The company had revenue of $5.54 billion for the quarter, compared to the consensus estimate of $4.71 billion. Equities analysts anticipate that Fresenius Medical Care AG will post 1.51 EPS for the current fiscal year.

Fresenius Medical Care Increases Dividend

The firm also recently declared an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Friday, May 23rd will be issued a $0.7871 dividend. This represents a dividend yield of 1.9%. The ex-dividend date is Friday, May 23rd. This is an increase from Fresenius Medical Care's previous annual dividend of $0.44. Fresenius Medical Care's dividend payout ratio is 49.11%.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Want to see what other hedge funds are holding FMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fresenius Medical Care AG (NYSE:FMS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.